
Ted M. Wang
Examiner (ID: 15234, Phone: (571)272-3053 , Office: P/2633 )
| Most Active Art Unit | 2633 |
| Art Unit(s) | 2634, 2633, 2611 |
| Total Applications | 1542 |
| Issued Applications | 1399 |
| Pending Applications | 39 |
| Abandoned Applications | 107 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11469669
[patent_doc_number] => 20170056453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'FERTILIZED EGG ISOLATE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/094816
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16506
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15094816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/094816 | FERTILIZED EGG ISOLATE AND USES THEREOF | Apr 7, 2016 | Abandoned |
Array
(
[id] => 11441956
[patent_doc_number] => 20170042977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE'
[patent_app_type] => utility
[patent_app_number] => 15/077046
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 44746
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077046
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/077046 | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE | Mar 21, 2016 | Abandoned |
Array
(
[id] => 11441956
[patent_doc_number] => 20170042977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE'
[patent_app_type] => utility
[patent_app_number] => 15/077046
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 44746
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077046
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/077046 | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE | Mar 21, 2016 | Abandoned |
Array
(
[id] => 11441959
[patent_doc_number] => 20170042978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'CNS DELIVERY OF THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/016141
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 147
[patent_figures_cnt] => 147
[patent_no_of_words] => 93228
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15016141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/016141 | CNS delivery of therapeutic agents | Feb 3, 2016 | Issued |
Array
(
[id] => 11002554
[patent_doc_number] => 20160199503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'MODIFIED BLOOD FACTORS COMPRISING A LOW DEGREE OF WATER SOLUBLE POLYMER'
[patent_app_type] => utility
[patent_app_number] => 14/991172
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15966
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991172
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/991172 | MODIFIED BLOOD FACTORS COMPRISING A LOW DEGREE OF WATER SOLUBLE POLYMER | Jan 7, 2016 | Abandoned |
Array
(
[id] => 11728018
[patent_doc_number] => 20170189461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'METHOD OF PREPARING FERMENTED CRUDE EXTRACT HAVING ANGIOTENSIN CONVERTING ENZYME INHIBITING ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/985810
[patent_app_country] => US
[patent_app_date] => 2015-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4104
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985810
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/985810 | Method of preparing fermented crude extract having angiotensin converting enzyme inhibiting activity | Dec 30, 2015 | Issued |
Array
(
[id] => 10782964
[patent_doc_number] => 20160129121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'FACTOR VIIA-POLYSIALIC ACID CONJUGATES HAVING PROLONGED IN VIVO HALF-LIFE'
[patent_app_type] => utility
[patent_app_number] => 14/946286
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9233
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14946286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/946286 | Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life | Nov 18, 2015 | Issued |
Array
(
[id] => 13079443
[patent_doc_number] => 10059779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Enzymatically polymerized gelling dextrans
[patent_app_type] => utility
[patent_app_number] => 14/933128
[patent_app_country] => US
[patent_app_date] => 2015-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 34989
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/933128 | Enzymatically polymerized gelling dextrans | Nov 4, 2015 | Issued |
Array
(
[id] => 10705818
[patent_doc_number] => 20160051965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'ABSORBANT AND DIGESTER FOR CARBON-BASED SUBSTANCES SUCH AS OIL'
[patent_app_type] => utility
[patent_app_number] => 14/830723
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1851
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14830723
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/830723 | ABSORBANT AND DIGESTER FOR CARBON-BASED SUBSTANCES SUCH AS OIL | Aug 18, 2015 | Abandoned |
Array
(
[id] => 15057239
[patent_doc_number] => 10458916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Rapid tests for the detection of inhibitors of enzymes and human exposure to the same
[patent_app_type] => utility
[patent_app_number] => 14/827674
[patent_app_country] => US
[patent_app_date] => 2015-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 8146
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14827674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/827674 | Rapid tests for the detection of inhibitors of enzymes and human exposure to the same | Aug 16, 2015 | Issued |
Array
(
[id] => 10684342
[patent_doc_number] => 20160030486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'PREPARATION OF COMPOSITIONS TO TREAT AND TREATMENT OF OSTEOARTHRITIS USING ADIPOSE-DERIVED STROMAL VASCULAR FRACTION CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/823586
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25055
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14823586
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/823586 | PREPARATION OF COMPOSITIONS TO TREAT AND TREATMENT OF OSTEOARTHRITIS USING ADIPOSE-DERIVED STROMAL VASCULAR FRACTION CELLS | Aug 10, 2015 | Abandoned |
Array
(
[id] => 13223161
[patent_doc_number] => 10125347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Method for stimulating the expression of specific tissue morphologies in filamentous fungi
[patent_app_type] => utility
[patent_app_number] => 14/745881
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2684
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745881
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745881 | Method for stimulating the expression of specific tissue morphologies in filamentous fungi | Jun 21, 2015 | Issued |
Array
(
[id] => 13168363
[patent_doc_number] => 10100286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Systems and methods of dissociating aggregate spheres of cells
[patent_app_type] => utility
[patent_app_number] => 14/744200
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 15
[patent_no_of_words] => 5332
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744200
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744200 | Systems and methods of dissociating aggregate spheres of cells | Jun 18, 2015 | Issued |
Array
(
[id] => 12238506
[patent_doc_number] => 20180071370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'METHOD TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/530666
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11024
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15530666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/530666 | Method to improve safety and efficacy of anti-cancer therapy | Jun 18, 2015 | Issued |
Array
(
[id] => 10712695
[patent_doc_number] => 20160058842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'FACTOR VIII POLYMER CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/736870
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8816
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/736870 | FACTOR VIII POLYMER CONJUGATES | Jun 10, 2015 | Abandoned |
Array
(
[id] => 16406962
[patent_doc_number] => 10815506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-27
[patent_title] => Production of fatty acid alkyl esters with caustic treatment
[patent_app_type] => utility
[patent_app_number] => 15/312230
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15978
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312230 | Production of fatty acid alkyl esters with caustic treatment | May 27, 2015 | Issued |
Array
(
[id] => 11744251
[patent_doc_number] => 20170198323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER'
[patent_app_type] => utility
[patent_app_number] => 15/313285
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38121
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313285 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | May 21, 2015 | Abandoned |
Array
(
[id] => 10362170
[patent_doc_number] => 20150247176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'STARCH SPHERULITES HAVING CONTROLLED ENZYMATIC DIGESTION'
[patent_app_type] => utility
[patent_app_number] => 14/714457
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7274
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714457
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/714457 | Starch spherulites having controlled enzymatic digestion | May 17, 2015 | Issued |
Array
(
[id] => 15160765
[patent_doc_number] => 10485855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Demonstrable efficacy across or within patient populations
[patent_app_type] => utility
[patent_app_number] => 14/702269
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10424
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14702269
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/702269 | Demonstrable efficacy across or within patient populations | Apr 30, 2015 | Issued |
Array
(
[id] => 10331945
[patent_doc_number] => 20150216949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/685628
[patent_app_country] => US
[patent_app_date] => 2015-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9564
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685628
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/685628 | Methods of treating cancer of the central nervous system | Apr 13, 2015 | Issued |